| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/07/2006 | EP1664272A2 Targeting endothelium for tissue-specific delivery of agents |
| 06/07/2006 | EP1664270A1 Chimeric antigens for breaking host tolerance to foreign antigens |
| 06/07/2006 | EP1664268A2 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 06/07/2006 | EP1664267A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 06/07/2006 | EP1664123A2 Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
| 06/07/2006 | EP1664117A2 Immunogen |
| 06/07/2006 | EP1664115A2 Antibody cdr polypeptide sequences with restricted diversity |
| 06/07/2006 | EP1664114A1 Method for producing a polypeptide |
| 06/07/2006 | EP1664113A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 06/07/2006 | EP1664112A2 Chimeric gabab receptor |
| 06/07/2006 | EP1664111A1 Test system for the identification of apj receptor ligands |
| 06/07/2006 | EP1664110A1 A continuous process for the assembly of macromolecular substances and the subsequent capture and isolation of a macromolecular assembly, and a system suitable for the process |
| 06/07/2006 | EP1664109A1 Purification of glucagon-like peptides |
| 06/07/2006 | EP1664108A1 Separation of polypeptides comprising a racemized amino acid |
| 06/07/2006 | EP1664107A2 Synthetic antimicrobial polypeptides |
| 06/07/2006 | EP1664106A1 Adipocyte complement related protein zacrp11 |
| 06/07/2006 | EP1664105A2 Vegf-induced genes and their therapeutic use |
| 06/07/2006 | EP1664104A1 A protein involved in carcinoma |
| 06/07/2006 | EP1664103A2 Genetic products which are differentially expressed in tumours and use thereof |
| 06/07/2006 | EP1664102A1 Isolated photoprotein mtclytin, and use thereof |
| 06/07/2006 | EP1664101A2 Epilancin 15x lantibiotic |
| 06/07/2006 | EP1664100A2 Lawsonia intracellularis subunit vaccine |
| 06/07/2006 | EP1664099A2 Adenoviral epitopes |
| 06/07/2006 | EP1664098A1 Immortalisation of mammalian cells and therapeutic applications of said cells |
| 06/07/2006 | EP1664097A2 Piroplasmid vaccine |
| 06/07/2006 | EP1664096A1 Antimicrobial polypeptides |
| 06/07/2006 | EP1664095A2 Antimicrobial polypeptides |
| 06/07/2006 | EP1664094A1 COMPOSITION FOR PROTECTING PROTEINS DEGRADATION COMPRISING SMALL HEAT SHOCK PROTEINS (sHSPs) AND METHOD OF TWO-DIMENSIONAL GEL ELECTROPHORESIS USING THE sHSPs |
| 06/07/2006 | EP1664086A1 Chromatographic separation of therapeutic polypeptides |
| 06/07/2006 | EP1664083A1 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation |
| 06/07/2006 | EP1664081A2 Novel proteins and nucleic acids encoding same |
| 06/07/2006 | EP1664075A2 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 06/07/2006 | EP1663310A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby |
| 06/07/2006 | EP1663307A2 Method for treating, preventing and/or diagnosing cancer, related to the use of mal2 polypeptide |
| 06/07/2006 | EP1663301A1 Vaccines |
| 06/07/2006 | EP1663295A2 Stable formulations of peptides |
| 06/07/2006 | EP1663294A1 Treatment of fibrotic disease |
| 06/07/2006 | EP1663293A2 Vege-cor vege-d materials and methods for stimulation of neural stem cells |
| 06/07/2006 | EP1663291A2 Recombinant lubricin molecules and uses thereof |
| 06/07/2006 | EP1663290A2 Modulators of p-selectin glycoprotein ligand 1 |
| 06/07/2006 | EP1663288A2 Methods of using wisp antagonists |
| 06/07/2006 | EP1663286A2 In vivo modulation of neuronal transport |
| 06/07/2006 | EP1663281A2 Poly-pegylated protease inhibitors |
| 06/07/2006 | EP1663279A2 Modified protease inhibitors |
| 06/07/2006 | EP1663146A2 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 06/07/2006 | EP1663118A2 Peptide-based conditioners and colorants for hair, skin, and nails |
| 06/07/2006 | EP1663110A2 Uses of interferons with altered spatial structure |
| 06/07/2006 | EP1662867A2 Insecticidal compounds and methods for selection thereof |
| 06/07/2006 | EP1662863A2 Transgenic tieg non-human animals |
| 06/07/2006 | EP1662862A1 Receptor |
| 06/07/2006 | EP1576157A4 Fluorescent proteins from copepoda species and methods for using same |
| 06/07/2006 | EP1537215B1 Zinc-regulated prokaryotic expression cassettes |
| 06/07/2006 | EP1534833A4 Mammalian grainyhead transcription factors |
| 06/07/2006 | EP1534718A4 Chemical synthesis of reagents for peptide coupling |
| 06/07/2006 | EP1502114A4 THE METHOD FOR MEASURING THE AMOUNT OF $g(b)iG-H3 PROTEIN AND DIAGNOSTIC KIT USING THE SAME |
| 06/07/2006 | EP1501942A4 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 06/07/2006 | EP1456379A4 Compositions and methods for modulating plant development |
| 06/07/2006 | EP1434787A4 Lp mammalian proteins; related reagents |
| 06/07/2006 | EP1434783A4 Lp mammalian proteins; related reagents |
| 06/07/2006 | EP1434493B1 Flax protein isolate and production |
| 06/07/2006 | EP1409673B1 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1352091B1 Compositions and methods enabling a totally internally controlled amplification reaction |
| 06/07/2006 | EP1323732B1 Beta-catenin nuclear localizing protein |
| 06/07/2006 | EP1315738A4 Extended native chemical ligation |
| 06/07/2006 | EP1313849B1 Methods for producing cloned avians |
| 06/07/2006 | EP1309690B1 Mfq-111, a human gtpase like protein |
| 06/07/2006 | EP1301536B1 Modulation of tetraspanin function |
| 06/07/2006 | EP1274725B1 Use of hev polypeptides |
| 06/07/2006 | EP1268514B1 Methods for purifying highly anionic proteins |
| 06/07/2006 | EP1265630B1 Use of insulin for the treatment of cartilagenous disorders |
| 06/07/2006 | EP1254234B1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 06/07/2006 | EP1254216B1 Improved galactosylation of recombinant glycoproteins |
| 06/07/2006 | EP1171594B1 Vascular endothelial cell growth factor variants and uses thereof |
| 06/07/2006 | EP1107794B1 Therapeutic compositions for the treatment of mucus hypersecretion |
| 06/07/2006 | EP1105419B1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 06/07/2006 | EP1095059B1 Chemotaxis inhibiting protein of staphylococcus (chips) and its use |
| 06/07/2006 | EP1081224B1 Novel method for cloning a gene |
| 06/07/2006 | EP1068233B1 Transcription factors and their use |
| 06/07/2006 | EP1051620B1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 06/07/2006 | EP1038015B1 Mood disorder gene |
| 06/07/2006 | EP1034188B1 Method of designing agonists and antagonists to igf receptor (1-462) |
| 06/07/2006 | EP1017789B1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0969873B1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 06/07/2006 | EP0939767B1 Porcine factor viii and hybrids thereof |
| 06/07/2006 | EP0885293B1 Human chemokine polypeptides |
| 06/07/2006 | EP0871735B1 Therapeutic compositions for the treatment of Lawsonia intracellularis infections |
| 06/07/2006 | EP0813606B1 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | EP0797675B1 Reversible nuclear genetic system for male sterility in transgenic plants |
| 06/07/2006 | EP0772437B1 Compositions for delivery of genetic material |
| 06/07/2006 | EP0719335B1 Hybrid toxin |
| 06/07/2006 | CN1784496A Multiple gene transcription activity determining system |
| 06/07/2006 | CN1784493A Modified beta-lactamases and uses thereof |
| 06/07/2006 | CN1784425A Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 |
| 06/07/2006 | CN1784424A Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 06/07/2006 | CN1784423A Peptides for use in treating obesity |
| 06/07/2006 | CN1784422A Severe acute respiratory syndrome (SARS) causing coronavirus |
| 06/07/2006 | CN1784421A Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation |